Diastereoselective conjugate addition of cyanide to α,β- unsaturated oxazolidinones: Enantioselective synthesis of ent-pregabalin and baclofen

Synlett

Volumn , Issue 10, 2006, Pages 1589-1591

  Armstrong, Alan ^a   Convine, Nicola J ^a   Popkin, Matthew E ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Conjugate addition; Cyanide; Oxazolidinone; Samarium

Indexed keywords

BACLOFEN; CYANIDE; OXAZOLIDINONE DERIVATIVE; PREGABALIN; SAMARIUM; SAMARIUM ISOPROPOXIDE; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CATALYSIS; CHEMICAL REACTION; CHIRALITY; CONJUGATION; DIASTEREOISOMER; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOSELECTIVITY; STEREOCHEMISTRY;

EID: 33745712063     PISSN: 09365214     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-941584     Document Type: Article

References (30)

1. (a) Review of conjugate addition of cyanide: Nagata, W.; Nozaki, H. Org. React. 1977, 25, 255.
2. (b) For cyanide group manipulations, see: North, M. Tetrahedron: Asymmetry 2003, 14, 147; and references therein.
3. (c) For a review of stereoselective conjugate addition, see: Armstrong, A.; Convine, N. J. In Comprehensive Organic Functional Group Transformations II, Vol. 1; Katritzky, A. R.; Taylor, R. J. K.; Cossy, J., Eds.; Elsevier Pergamon: Oxford, 2005, 287; and references therein.
4. (a) Sammis, G. M.; Jacobsen, E. N. J. Am. Chem. Soc. 2003, 125, 4442.
5. (b) Sammis, G. M.; Danjo, H.; Jacobsen, E. N. J. Am. Chem. Soc. 2004, 126, 9928.
6. Mita, T.; Sasaki, K.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2005, 127, 514.
7. For selected diastereoselective approaches, see: (a) Dahuron, N.; Langlois, N. Synlett 1996, 51.
8. (b) Garcia Ruano, J. L.; Cifuentes Garcia, M.; Laso, N. M.; Martin Castro, A. M.; Rodriguez Ramos, J. H. Angew. Chem. Int. Ed. 2001, 40, 2507.
9. (c) Acherki, H.; Alvarez-Ibarra, C.; Dios, A.; Quiroga, M. L. Tetrahedron 2002, 58, 3217.
10. (d) Benedetti, F.; Berti, F.; Garau, G.; Martinuzzi, I.; Norbedo, S. Eur. J. Org. Chem. 2003, 1973.
11. (e) Steurer, S.; Podlech, J. Eur. J. Org. Chem. 2002, 899.
12. Kawasaki, Y.; Fujii, A.; Nakano, Y.; Sakaguchi, S.; Ishii, Y. J. Org. Chem. 1999, 64, 4214.
13. Evans, D. A.; Chapman, K. T.; Bisaha, J. J. Am. Chem. Soc. 1988, 110, 1238.
14. 3: 242.1505; found: 242.1498.
15. Details will be provided in a full account of this work. We thank Dr. A. J. P. White, Dept. of Chemistry, Imperial College London, for this structure determination.
16. (a) Hoekstra, M. S.; Sobieray, D. M.; Schwindt, M. A.; Mulhern, T. A.; Grote, T. M.; Huckabee, B. K.; Hendrickson, V. S.; Franklin, L. C.; Granger, E. J.; Karrick, G. L. Org. Process Res. Dev. 1997, 1, 26.
17. (b) Burk, M. J.; de Koning, P. D.; Grote, T. M.; Hoekstra, M. S.; Hoge, G.; Jennings, R. A.; Kissel, W. S.; Le, T. V.; Lennon, I. C.; Mulhern, T. A.; Ramsden, J. A.; Wade, R. A. J. Org. Chem. 2003, 68, 5731.
18. (c) Burk, M. J.; Goel, O. P.; Hoekstra, M. S.; Mich, T. F.; Mulhern, T. A.; Ramsden, J. A. WO01 55090, 2001.
19. (d) Hoge, G. J. Am. Chem. Soc. 2003, 125, 10219.
20. (e) Brenner, M.; Seebach, D. Helv. Chim. Acta 1999, 82, 2365.
21. (f) See also ref. 2a and 3.
22. For selected approaches to (R)-baclofen employing conjugate addition as the key step, see: (a) Corey, E. J.; Zhang, F.-Y. Org. Lett. 2000, 2, 4257.
23. (b) Baldoli, C.; Maiorana, S.; Licandro, E.; Perdicchia, D.; Vandoni, B. Tetrahedron: Asymmetry 2000, 11, 2007.
24. (c) Licandro, E.; Maiorana, S.; Baldoli, C.; Capella, L.; Perdicchia, D. Tetrahedron: Asymmetry 2000, 11, 975.
25. (d) Meyer, O.; Becht, J.-M.; Helmchen, G. Synlett 2003, 1539.
26. (e) Becht, J.-M.; Meyer, O.; Helmchen, G. Synthesis 2003, 2805.
27. Olpe, H.-R.; Demieville, H.; Baltzer, W. L.; Koella, W. P.; Wolf, P.; Hass, H. L. Eur. J. Pharmacol. 1978, 52, 133.
28. Puetz, C.; Przewosny, M. T. WO03 062185, 2003.
29. (a) Thakur, V. V.; Nikalje, M. D.; Sudalai, A. Tetrahedron: Asymmetry 2003, 14, 581.
30. (b) Caddick, S.; Judd, D. B.; de Lewis, A. K. K.; Reich, M. T.; Williams, M. R. V. Tetrahedron 2003, 59, 5417.